Anzeige
❌
Mehr »
Montag, 26.10.2026 - Börsentäglich über 12.000 News
25+ Jahre Tiefsee-Erfahrung: Wie Ölexperten für SEAS den Abbau von Meeresbodenmineralien vorantreiben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
228 Leser
Artikel bewerten:
(1)

Lira Clinical Announces New REGEN Line - A First-of-Its-Kind Breakthrough in Regenerative Skincare

LIVERMORE, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lira Clinical, a global leader in corrective and brightening skincare, is proud to announce the launch of its groundbreaking new REGEN line. REGEN is the first and only clinical skincare line formulated with Wild Salmon Stem Cell-Conditioned Media - a revolutionary ingredient that delivers more regenerative power than PDRN alone.

Developed in collaboration with Wildtype, the REGEN line is a major breakthrough in PROAging skincare and the emerging category of Clinical Brightening. The REGEN line's exclusive combination of Wild Salmon Stem Cell-CM (aka Marine Cellular Complex), PDRN, and Copper Tripeptide-1 promotes healthier, brighter skin from the inside out by supporting the key drivers of skin health: hydration, circulation, and firmness.

Lira Clinical REGEN PDRN+ Crème and Serum

REGEN's unique benefits are delivered deep into the skin by Lira Clinical's proprietary EXO-tech phospholipid encapsulation technology, which carries active ingredients through the acid mantle without compromising their efficacy or damaging the skin's protective barrier.

Wild Salmon Stem Cell-CM: A Full-Spectrum Regenerative Approach to Skincare

Wild Salmon Stem Cell-Conditioned Media, aka Marine Cellular Complex (MCC), is a next-generation regenerative complex containing nearly 2,000 different bioactive growth factors, salmon-derived exosomes, thousands of peptides, antioxidants, and stem cells that promote collagen repair and structural support while visibly reducing redness and inflammation.

Lira Clinical's REGEN Line is the first to introduce this innovation and its benefits to the global aesthetic market.

"Lira Clinical's core values have always been about real people, real results, with more clinical studies to come. PDRN is a buzzword now, but Lira is the first company to introduce wild salmon stem cell-conditioned media that now goes beyond the benefits of PDRN. We were able to formulate both a serum and a creme for in-clinic and home treatments."

Metaxia Dalikas, co-founder and CEO, Lira Clinical

The REGEN Line

Lira Clinical's REGEN line is available in two formats:

REGEN PDRN+ Serum - the first and only serum in the clinical market to combine Wild Salmon Stem Cell-CM with PDRN and Copper Tripeptide-1, delivering more regenerative power than PDRN alone to rebuild skin from within

REGEN PDRN+ Crème - a volumizing formulation that restores skin density, improves structure, and extends Clinical Brightening benefits by improving hydration, circulation, and firmness

Availability

The REGEN line is available through Lira Clinical's professional channels and international distributors worldwide.

Clinical Brightening: Beyond Surface Correction

Unlike traditional brightening skincare that corrects dark spots and dull, uneven, tired-looking skin at the surface, Clinical Brightening addresses their underlying causes, supporting the skin's natural renewal process to improve hydration, circulation, and firmness. The result is skin that immediately looks brighter, smoother, healthier, and more alive.

Lira Clinical Skincare: Real People. Real Results.

A global leader at the forefront of skincare innovation, Lira Clinical was founded by four renowned skincare professionals dedicated to providing real results for real people, in the form of brighter, healthier, younger-looking skin. Lira Clinical's core philosophy, Science Discovering Nature's Secrets, reflects the company's deep understanding of how modern biotechnology can unlock the regenerative potential found in nature to treat skin conditions and improve skin health.

Wildtype: Defending the Earth's Wild Places

Wildtype, the San Francisco-based cultivated seafood company, is now expanding into skincare with its Marine Cellular Complex (MCC), a novel, animal-free, ocean-positive skincare science product.

Marine Cellular Complex is made from 15,540 peptides and 5,105 proteins grown from salmon cells, not actual salmon. The process is animal-free and ocean-positive, meaning it doesn't harm wild fish populations. The complex contains a rich blend of proteins, lipids, antioxidants, salmon-derived exosomes, collagen, elastin, and other bioactive molecules that are known for their skin-benefiting properties.

Media Inquiries

Francine Kagarakis
Co-founder and CIO of Lira Clinical
francine@liraclinical.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/61eab243-fc42-43d7-a84f-660369223922


© 2026 GlobeNewswire (Europe)
Historische Öl-Krise - 5 Aktien, die davon profitieren!
Der Iran-Krieg hat den globalen Energiemarkt erschüttert. Zerstörte Förderanlagen, ausgefallene Transportwege und fehlende Raffineriekapazitäten sorgen dafür, dass nicht nur Rohöl, sondern vor allem Benzin und Diesel knapp und teuer bleiben könnten. Selbst ein Ende der Kämpfe würde das Problem nicht über Nacht lösen, der Wiederaufbau der Energieinfrastruktur dürfte Jahre dauern.

Während viele Anleger jetzt auf ExxonMobil, Chevron oder Shell setzen, könnte das größere Potenzial längst woanders liegen. Denn hohe Ölpreise machen neue Investitionen in Förderung, Transport und Verarbeitung wieder attraktiv. Davon profitieren vor allem jene Unternehmen, die Bohrtechnik, Ausrüstung und Dienstleistungen bereitstellen oder bereits über wertvolle Infrastruktur verfügen.

Hier dürfte die zweite Welle des Öl-Booms entstehen. Statt den bereits stark gelaufenen Produzenten hinterherzulaufen, können Anleger auf die Unternehmen setzen, die am milliardenschweren Wiederaufbau der globalen Energieinfrastruktur verdienen.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, die von der historischen Öl-Krise besonders profitieren könnten.

Jetzt den kostenlosen Report sichern und die möglichen Gewinner der zweiten Öl-Welle entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.